Clinical Trial Update: Head to Head Study Epi proColon and FIT

View source ↗

Summary

A completed head-to-head clinical trial comparing the Epi proColon blood test with the fecal immunochemical test (FIT) for colorectal cancer screening.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Epi proColon
• Fecal Immunochemical Test (Fecal immunochemical test)

Snippet

Sponsor: Epigenomics, Inc | Conditions: Colorectal Cancer | Status: COMPLETED